In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 5, 2002, Pages 1581-1582

  Sun, Qiu N ^a   Fothergill, Annette W ^a   McCarthy, Dora I ^a   Rinaldi, Michael G ^a   Graybill, John R ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; MUCORMYCOSIS; NONHUMAN; PRIORITY JOURNAL; ZYGOMYCETES;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; TRIAZOLES; ZYGOMYCOTA;

EID: 0036233027     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.5.1581-1582.2002     Document Type: Article

References (14)

1. Cardiac fungal infection: Review of autopsy findings in 60 patients
2. An amphotericin B-resistant case of rhinocerebral mucormycosis
3. In vitro studies of activities of the antifungal triazole SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeast
4. Activity of the triazole SCH 56592 against disseminated murine coccidoidomycosis
5. Fungal burn wound infection
6. In vitro activity of SCH56592 and comparison with activity of amphotericin B and itraconazole against Aspergillus spp
7. Fatal opportunistic fungus disease
8. Rhinocerebral zygomycosis
9. Zygomycetes in human disease
10. In vitro and in vivo activity of SCH 56592 against Blastomyces dermatitidis
11. Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis, and management
12. Fungal infections in liver transplant recipients